Dean Whiting warns Australia has a narrow window to implement systemic change before healthcare becomes unsustainable
January 2025 – Pathology Technology Australia (PTA) CEO Dean Whiting has delivered a sobering assessment of the healthcare sector’s trajectory, warning that critical policy initiatives have stalled despite the government’s return to office earlier this year.
Speaking with Health Industry Hub, Whiting described widespread frustration among PTA members as key reviews—including Point of Care Testing, the Pathology Review, and HTA review—have fallen “significantly behind the timeline originally stated.”
“The beginning of 2025 was marked by a resounding return of the government, which we expected would result in a rapid resumption of the initiatives that were already in play for us,” Whiting said. “Disappointingly, all of these have stalled.”
A Crossroad for Australian Healthcare
The sentiment among PTA members, Whiting reports, is “very difficult,” with many feeling disheartened about the direction of healthcare in Australia.
“We’re at a crossroad here with healthcare in general, and certainly my members are reflecting that,” he said.
Whiting’s concerns extend beyond immediate policy delays to the sustainability of Australia’s healthcare system itself. He warns that without urgent action, the system faces a critical tipping point.
“Healthcare is rapidly becoming unsustainable. We potentially have 10, maybe 12 years to complete systemic changes before some are suggesting we will hit a real cliff,” Whiting cautioned. “We have the technology available to start the transition to a much more sustainable system that will give us better patient outcomes at a lower total cost to the economy.”
“Pivotal” Moment Demands Action
Describing 2025 as “pivotal,” Whiting emphasised the urgency of establishing a clear vision and roadmap for healthcare transformation.
“We need to start to set the vision and the roadmap for systemic change in healthcare in Australia,” he stressed. “We will run out of time to make that transition.”
Despite the pathology technology sector’s significant contribution to patient outcomes, Whiting noted a stark funding disparity: “The pathology sector in general attracts only about 3% of the total healthcare budget… The contribution of our members and their technology to patient outcomes is huge, but the funding for healthcare technology is extremely low.”
Moving forward, Whiting reaffirmed PTA’s commitment to collaboration as the key to driving meaningful change, working broadly with partner organisations to advance the sector’s advocacy goals.
Listen to the interview here: https://www.healthindustryhub.com.au/medical-technology-news-trends/diagnostics-on-the-edge-will-policy-catch-up-before-health-plunges-over-the-cliff/